Key Events This Week
Jan 5: Technical momentum shifts amid mixed market signals
Jan 8: Downgrade to Strong Sell amid weak financials and bearish technicals
Jan 9: Intensified downtrend with technical weakness and market underperformance
Jan 9: Week closes at ₹77.00 (-4.91%)

Anuh Pharma Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals
2026-01-09 08:13:39Anuh Pharma Ltd has been downgraded from a Sell to a Strong Sell rating as of 8 January 2026, reflecting deteriorating technical indicators and disappointing financial performance. The pharmaceutical company’s shares have underperformed the broader market, with key parameters such as quality, valuation, financial trend, and technicals all contributing to the revised outlook.
Read full news article
Anuh Pharma Ltd Faces Intensified Downtrend Amid Technical Weakness and Market Underperformance
2026-01-09 08:07:11Anuh Pharma Ltd has experienced a marked shift in its technical momentum, with key indicators signalling a deteriorating outlook. The company’s Mojo Grade was downgraded from Sell to Strong Sell on 8 January 2026, reflecting growing bearish sentiment amid weakening price action and technical trends. This article analyses the recent price movements, technical indicator signals, and broader market context to provide a comprehensive view of Anuh Pharma’s current positioning.
Read full news article
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-01-05 08:07:03Anuh Pharma Ltd has exhibited a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook as of early January 2026. Despite a modest day gain of 2.65%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, price action, and comparative performance against the broader market to provide a comprehensive view for investors.
Read full news articleAnuh Pharma Gains 0.83%: 5 Key Factors Driving the Week’s Mixed Momentum
2026-01-03 15:30:00
Key Events This Week
29 Dec 2025: Stock opens at Rs.80.31, closes at Rs.80.92 (+0.76%) amid technical upgrade
30 Dec 2025: Rating upgraded to 'Sell' from 'Strong Sell' by MarketsMOJO
31 Dec 2025: Bearish momentum intensifies, stock dips to Rs.79.99 (-1.15%)
1 Jan 2026: Mixed technical signals as stock recovers slightly to Rs.80.48 (+0.61%)
2 Jan 2026: Stock closes at Rs.80.98 (+2.65%) with renewed buying interest

Anuh Pharma Ltd Faces Bearish Momentum Amid Technical Downturn and Market Underperformance
2026-01-02 08:11:38Anuh Pharma Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling increased selling pressure and subdued investor sentiment as the stock price declined to ₹78.75 on 2 Jan 2026.
Read full news article
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-01-01 08:07:39Anuh Pharma Ltd has exhibited a subtle shift in its technical momentum as it transitions from a bearish to a mildly bearish trend, reflecting a nuanced market sentiment. Despite a modest daily gain of 0.83%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, underscoring the challenges faced by investors in the Pharmaceuticals & Biotechnology sector.
Read full news articleCorporate Actions
No Upcoming Board Meetings
Anuh Pharma Ltd has declared 30% dividend, ex-date: 14 Aug 25
Anuh Pharma Ltd has announced 5:10 stock split, ex-date: 31 Jul 06
Anuh Pharma Ltd has announced 1:1 bonus issue, ex-date: 15 Jul 25
No Rights history available








